Xu, Yingqi <br/><br/>
Dihydromyricetin Induces Apoptosis and Reverses Drug Resistance in Ovarian Cancer Cells by p53-mediated Downregulation of Survivin.  [electronic resource] 

 -  Scientific reports  04 2017 
 - 46060 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2045-2322 
<br/><br/><label>Standard No.: </label>10.1038/srep46060  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Apoptosis--drug effects<br/>Cell Cycle Checkpoints--drug effects<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cell Shape--drug effects<br/>Down-Regulation--drug effects<br/>Doxorubicin--pharmacology<br/>Drug Resistance, Neoplasm--drug effects<br/>Female<br/>Flavonols--chemistry<br/>Humans<br/>Inhibitor of Apoptosis Proteins--metabolism<br/>Ovarian Neoplasms--metabolism<br/>Paclitaxel--pharmacology<br/>S Phase--drug effects<br/>Signal Transduction--drug effects<br/>Survivin<br/>Tumor Suppressor Protein p53--metabolism